18 March 2025
Advocating for Military Medical Research: Geneva Leadership Visits Capitol Hill
Members of Geneva’s Board of Directors, Scientific Advisory Board, and Leadership Team traveled to Washington, D.C., for a series of strategic meetings with Congressional leaders from Colorado, North Carolina, Texas, and Washington. These visits underscore the critical need for sustained defense appropriations that support groundbreaking military medical research initiatives, ensuring continued innovation in warfighter health and readiness.
Some key focal points of discussions with Congressional leaders included funding for research and development for deployment-limiting conditions, including musculoskeletal injury, continued investment in biotechnology capabilities to enhance battlefield additive manufacturing capabilities and offer new solutions for battlefield injuries, and pre-hospital care, including innovative programs designed to improve survivability and post-injury care for warfighters.
These visits served as an invaluable opportunity to engage with key policymakers and military health stakeholders, reinforcing Geneva’s commitment to advancing medical research that directly benefits the nation’s warfighters. Through continued collaboration with congressional leaders and Department of Defense partners, Geneva remains steadfast in its mission to drive innovation in military medicine and improve the lives of service members and veterans alike.
The organization extends its gratitude to all those who support these efforts and looks forward to furthering its impact through strategic advocacy and innovation in military medical research.
Geneva’s Advocacy Committee
Geneva’s Advocacy Committee, operating under the Board of Directors, is instrumental in crafting our advocacy strategies. The committee is composed of leaders with extensive backgrounds in various fields relevant to military medicine, including medical research management, policy-making, and legal frameworks within the military medical enterprise. Members bring a wealth of experience from high-level positions across military and civilian sectors, ranging from direct command in combat zones to strategic roles in military healthcare, research, and medical product development. This collective expertise empowers the committee to effectively shape Geneva’s advocacy initiatives and navigate complex policy environments to advance our mission.
Why Advocacy Now?
As the military healthcare landscape evolves rapidly, our active participation in shaping policies and leading discussions ensures that Geneva not only contributes but leads in military medical advancements.